Rossari Biotech Ltd (ROSSARI) Q4FY26 Management Mirror - Mar-2026 Qtr
Revenue & Growth
Management expects to maintain at least a similar growth rate in the upcoming year as achieved in the Mar'26 Qtr, with further upside potential if global macroeconomic conditions stabilize, while polymer segment margins are projected to approach double digits as revenues scale toward 780-1,000 crore; earlier in the Dec'25 Qtr, the company highlighted an expected sequential demand recovery and continued outperformance in export markets compared to sluggish domestic textile demand, following warnings in the Sep'25 Qtr of US tariff headwinds impacting textile volumes. [Status: Initiated]
2 more themes on the ELITE plan.